- Date: July 24, 2018
Spanish biotechnology companies received €149 million last year, 17% more than in 2016. The sector’s economic impact was worth 0.7% of Spanish GDP (€7.3 billion), and helped create over 108,000 jobs. These are some of the conclusions reached in the latest Annual Report published by the Spanish Association of Biotech Companies (ASEBIO).
In a breakdown by type of financial operation, the report highlights €93.7 million spent on increased private equity investments, €41 million in share capital increases, and €10.8 million on related operations and participation loans. There were also significant levels of venture capital activity in 2017, with entities in the sector, such as Caixa Capital Risc, investing a total of €30 million.
The report also provides data from the 2016 Innovation in Companies Survey carried out by the Spanish National Statistics Institute, showing that €617 million were invested in R&D in the Spanish biotechnology sector, 6.6% more than in 2015. The main area of activity is human health (66.8%), followed by food (23.5%). Most companies in the sector are found in the autonomous community of Catalonia (19.3%), followed by Andalusia (13.5%) and Galicia (8.6%).
October 15, 2018
EIT Health has launched the Investor Network, a European network that puts healthcare start-ups in touch with investors who are interested in financing the sector.
September 18, 2018
The COMPASS consultancy and mentoring scheme is open to start-ups and SMEs in the biomedicine, nanotechnology and cyber security sectors.
July 12, 2018
The magazine The Scientist has spent a decade publishing the latest biomedicine innovations in its annual Top 10 Innovations contest. Applications are already open for this year’s competition.